Correlation Between Spyre Therapeutics and Naked Wines

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Naked Wines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Naked Wines into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Naked Wines plc, you can compare the effects of market volatilities on Spyre Therapeutics and Naked Wines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Naked Wines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Naked Wines.

Diversification Opportunities for Spyre Therapeutics and Naked Wines

-0.28

Correlation Coefficient

Spyre Therapeutics  Naked Wines

Very good diversification

The 3 months correlation between Spyre and Naked is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Naked Wines plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Naked Wines plc and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Naked Wines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Naked Wines plc has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Naked Wines go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Naked Wines

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Naked Wines. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 1.52 times less risky than Naked Wines. The stock trades about -0.09 of its potential returns per unit of risk. The Naked Wines plc is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  255.00  in Naked Wines plc on December 28, 2024 and sell it today you would lose (25.00) from holding Naked Wines plc or give up 9.8% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	96.77%
Values	Daily Returns

Spyre Therapeutics  vs.  Naked Wines plc

Spyre Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Naked Wines plc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Naked Wines plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Naked Wines is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Spyre Therapeutics and Naked Wines

The main advantage of trading using opposite Spyre Therapeutics and Naked Wines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Naked Wines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Naked Wines will offset losses from the drop in Naked Wines' long position.

The idea behind Spyre Therapeutics and Naked Wines plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.